| Financial Year |
March 31 2023 |
| Monetary Funds |
2,436,774,305.87 |
| Held-for-trading Financial Assets |
903,440,547.94 |
| Notes Receivable |
-- |
| Accounts Receivable |
535,277,823.18 |
| Advances to Suppliers |
8,897,698.94 |
| Other Receivables |
3,362,209.86 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
953,612,657.49 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
125,181,332.05 |
| Total Current Assets |
5,147,843,888.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
687,630,183.81 |
| Under-construction Projects |
1,219,255,968.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
87,882,595.42 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
7,736,633.23 |
| Other Non-Current Assets |
376,870,866.32 |
| Sub-Total of Non-Current Assets |
2,379,739,175.99 |
| Total Assets |
7,527,583,064.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
439,024,088.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,978,045.78 |
| Taxes Payable |
44,021,693.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,364,906.50 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,506,098.92 |
| Other Current Liabilities |
2,094,308.47 |
| Sub-Total of Current Liabilities |
551,626,818.57 |
| Long-term Loans |
882,666,852.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,024,514,247.39 |
| Total Liabilities |
1,576,141,065.96 |
| Paid-In Capital(Or Share Stock) |
170,784,280.00 |
| Capital Surplus |
3,990,856,683.51 |
| Surplus Reserve |
85,392,140.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,699,519,659.44 |
| Minority Stockholder's Interest |
5,349,088.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,946,092,910.45 |
| Owner's Equity（Stockholder's Equity） |
5,951,441,998.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,527,583,064.71 |
